Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent! Thank you for sharing...nvlx mj side of business seems to be attracting lots of attention from lenders and investors. ..mgmt not looking to just give company away...feeling good about our mgmt decision making...2014 gonna be exciting!
It's all good Carson...we have been beating those guys back for years...made some of them retire. Now we have a bunch of basher fools...repeat and bump posters...core group of us deal with their nonsense...longs will win this fight....we have the goods. The other board has an ignore button...If you choose.
Well not only are we involved in the mj sector but we already have had successful CTs in using cell in box for pancreatic cancer...CT 3 is around the corner...building a nice team for our mj subsidiary...that's enough to get involved here...do your dd...lots of good info out there...Google the inventors of cell in box...Brian salmons and Walter gunzburg...gl
Hispeed...i agree. You can easily spot the shorting mms...my favorite begins with a "W"
Can you imagine the worth of this technology? Phase 2b confirmed prior results...no reason to think phase 3 will fail...once cancer sufferers are aware of this new treatment there will be unimaginable requests for its use. NVLX owns it and it beats results of current treatments...no brainer...accumulate accumulate accumulate
Today's seeking alpha writeup hits the nail on the head...its well written and touches on all aspects of cell in box. Everything from pancreatic cancer to diabetes and mj. Every investor should read this piece. It blows away every negative novice written hatchet job writeup by the novice writer on board here. Nuvilex will have its phase 3 and prove to the world that its tech is the next miracle in treating cancer...god bless nuvilex.
So is alan...he is worried about the mj part of this as we are headed to a phase 3 for pancreatic cancer...loeb and loeb...virusure...fisher bio and inno bio all on board. Next up the CRO selection and alan is worried about mj? Smh...
Lol..."nothing material going on"...just spit my nightcap...virusure...fisher bio...inno bio...loeb and loeb...phase 3 approaching. I do appreciate the humor!
Thanks Fox...these few including the nutcase blogger have an agenda to scare investors away...they probably want to buy cheap...smart investors have done their dd and are accumulating and holding. Few trying to flip the half penny...company seems to have accredited investors who believe...phase 3 on its way...
Baloney...nvlx got the goods...virusure...fisher...inno...and soon a CRO....then phase 3 enrollment. Stay long and strong and be rewarded.
Ahh I love that SA article...well written and unbiased. ..how bout you al?
Fact: nvlx signs deal with fisher bioservices... http://www.fisherbioservices.com/news
Ewww...weeee I got that tingle up my leg. I know nvlx has something special. Big stock blogger back here bashing lil 'ol penny stock. Big bad wolf...no one listening to his finra crap. Btw...ryan and crabtree are not "no bodies"...crabtree brought taxol to market. Theres a little dd for ya. Phase 3 coming!
Lol...I am talking about phase 2b not phase 2...heelloooooo
Recent phase 2b confirmed phase 2 results....do your dd.
Big pharma is always in the market to acquire new technology especially if it interferes with their own bottom line. Therefore you can bet lilly and celgene are looking at nvlx very carefully. Its also possible boehringer (being a partner of Inno biologics) is watching this.
Nvlx moving along just fine....all you folks thinking mj should shelve it for now...all attn being paid to phase 3 for pancreatic cancer...mj will have its day and we will be number one in that field too.
Lol...yes
Oh I dont know about that but fisher bio posted our signing on their website...smells good to me. Time is SHORT....lol
Good to see news being spread around.... http://www.contractpharma.com/contents/view_breaking-news/2013-09-17/nuvilex-selects-clone-partner/
Excellent post. Many will say "oh just another pr"...but not realize this info is verfiable on fisher's website. This move together with the loeb and loeb law firm contract signifies that a phase 3 is imminent and may be fast approaching. Dr ryan is taking the right approach and although we may think things are moving slowly he is doing it the right way...and his way is to ensure a successful phase 3. That is what it is all about...fda...big pharma buyout...etc..will fall in line after phase 3 is completed and results are released for fda review.
I am on your side.. I have held this stock for years and now feel they are onto something real big. Phase 2b confirmed phase 2 and now we look forward to phase 3. No reason to think it will fail...ryan and crabtree are sharp crabtree brought taxol to market when he was with bristol myers. Ryan has the fda connections they are putting all the pieces into place. The shorts made a mistake long ago and now are in panic mode. I agree we will see more antics from them. Glta longs....guard your shares.
You ask if cell in box is next?....no brainer.
Hey everyone...now this is an article worth reading... http://www.forbes.com/sites/jordanterry/2013/04/05/a-skeptics-take-on-nuvilex-after-speaking-with-management-patience-should-be-rewarded/
Oh I luv the stealth bashing...we know who they are. Nvlx now has the technology that was given european orphan status. Since then I am sure salmons and gunzburg have tweaked this tech and made it better. For all we know...doc Ryan is swatting away offers for this tech...lets see what happens in october when we are scheduled to acquire the rights for this tech to be used for diabetes...all lllll could break loose....
Dear alan...I did some dd for you. It was right under your nose. How bout that...read up boy...then go buy some. http://m.seekingalpha.com/article/1294911
I for one appreciate being informed about the company's development. Its way better than being kept in the dark and having to dig for any little info. I think this mgmt is taking a very careful approach to the next and very big step in it's development and that is phase 3. Nothing wrong with informing the public about the company while planning a phase 3...or would you rather be in the dark?...Doc Ryan keep those prs coming...
For any aspiring writers... http://www.ncbi.nlm.nih.gov/m/pubmed/16175235/
Lets look at it this way...we are going to use the same tech and drug we used to get the same results in phase 2b...we are again testing against pancreatic cancer in humans...results should be the same for phase 3 trial...no?
Time is short....some how that bozo talks about cinnergen etc...current website focuses on cancer...
Been a holder of this stock for years...have done my dd and respect all members of nvlx mgmt...check their backgrounds...crabtree brought taxol to market...his background speaks for itself...ryan has great experience with fda...some smart people running this show...seems any shorter would know by now this train cannot be stopped...they are trying but momo is too great...after guptas weed show on sunday nvlx could see more pps upward movement...glta longs
Hey p diddy...
Why dont you prance on over to the other board...we will welcome you. Its a bashers oasis over there...c'mon lets go. They need your help.
Boat still in dock...
No one has missed the boat yet...lots of upside. Phase 3 announcement alone is worth the ride...this is not a drug heading toward phase 3. It makes drug work better and causes less toxicity to body because a lower dose of drug is used. With this acquisition news and with ryan and crabtree (introduced taxol to market) this stock wont be down here long. However there are shorts in play here....
We got the real goods...
This is all I wanted to see...
From the 8k filing
This Licensing Agreement with Austrianova Singapore Pte Ltd. ("ASPL" or "ANS"), grants to the Registrant an exclusive worldwide license to use the Cell-In-A-Box? trademark and its associated technology.
Agreed...been here since efoodsafety days...this is a different company
Those paid pumpers serve their purpose....to increase awareness...thats what they are paid to do...simple as that.
Phase 1, 2 and 2b results are known...but phase 3 carries more weight as it involves more subjects...shorts are doing a good job in dismissing earlier CTs...a big pharma will carry nvlx into and passed phase 3...reread last few prs...they hint at big brother...
Honestly...lilly and celgene is not gonna let a small biotec (nvlx) interfere with their $$$$...nvlx will be bought out...
Celgenes abraxane is a form of taxol...nvlx crabtree brought taxol to market when with bristol myers...abraxane bests lillys gemzar...cell in box bests abraxane and gemzar...who wants to partner with nvlx to become new gold standard? Bidding war to develope? Maybe. ..